Ameriprise’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Sell |
1,623,503
-839,843
| -34% | -$2.02M | ﹤0.01% | 2530 |
|
|
2025
Q1 | $5.44M | Sell |
2,463,346
-1,148,279
| -32% | -$2.54M | ﹤0.01% | 2245 |
|
|
2024
Q4 | $19.7M | Buy |
3,611,625
+62,123
| +2% | +$339K | 0.01% | 1341 |
|
|
2024
Q3 | $29.5M | Buy |
3,549,502
+554,832
| +19% | +$4.61M | 0.01% | 1109 |
|
|
2024
Q2 | $21.4M | Sell |
2,994,670
-9,015
| -0.3% | -$64.5K | 0.01% | 1233 |
|
|
2024
Q1 | $26M | Buy |
3,003,685
+822,068
| +38% | +$7.13M | 0.01% | 1144 |
|
|
2023
Q4 | $14.3M | Sell |
2,181,617
-4,771
| -0.2% | -$31.3K | ﹤0.01% | 1480 |
|
|
2023
Q3 | $21.9M | Buy |
2,186,388
+511,387
| +31% | +$5.11M | 0.01% | 1164 |
|
|
2023
Q2 | $20.8M | Buy |
+1,675,001
| New | +$20.8M | 0.01% | 1229 |
|
|
2022
Q3 | – | Sell |
-53,995
| Closed | -$1.53M | – | 3997 |
|
|
2022
Q2 | $1.53M | Sell |
53,995
-49,151
| -48% | -$1.4M | ﹤0.01% | 2926 |
|
|
2022
Q1 | $3.64M | Buy |
103,146
+94,026
| +1,031% | +$3.32M | ﹤0.01% | 2624 |
|
|
2021
Q4 | $382K | Sell |
9,120
-373,238
| -98% | -$15.6M | ﹤0.01% | 3598 |
|
|
2021
Q3 | $18.8M | Sell |
382,358
-201,648
| -35% | -$9.89M | 0.01% | 1315 |
|
|
2021
Q2 | $24.4M | Buy |
584,006
+558,370
| +2,178% | +$23.3M | 0.01% | 1201 |
|
|
2021
Q1 | $913K | Buy |
25,636
+3,458
| +16% | +$123K | ﹤0.01% | 3179 |
|
|
2020
Q4 | $622K | Buy |
+22,178
| New | +$622K | ﹤0.01% | 3258 |
|